NEWSROOM

Blog

SKYX Provides Corporate Update, including Significant Insider Buying

SKYX Provides Corporate Update, including Significant Insider Buying

Oct 9, 2024

MIAMI, Oct. 09, 2024 - PRISM MediaWire - SKYX (NASDAQ: SKYX) (d/b/a "SKYX Technologies"), a highly disruptive smart platform technology company with over 97 issued and pending patents in the U.S. and globally, and which owns over 60 lighting and home décor websites with a mission to make homes and buildings become smart, safe, and advanced as the new standard, provides today a corporate update including significant insider buying. SKYX Secures $11 million equity preferred stock investment...

Oncocyte’s DetermaIO Immuno-Oncology Assay Predicts Response to Atezolizumab in Phase 2 Clinical Trial

Oncocyte’s DetermaIO Immuno-Oncology Assay Predicts Response to Atezolizumab in Phase 2 Clinical Trial

Oct 8, 2024

Results published in peer-reviewed journal, Clinical Cancer Research Study validates DetermaIO’s utility in identifying breast cancer patients most likely to benefit from atezolizumab DetermaIO targets a multi-billion-dollar addressable market in oncology diagnostics IRVINE, Calif., October 8, 2024 - PRISM MediaWire - Oncocyte Corp. (Nasdaq: OCX), a diagnostics technology company, announced the peer-reviewed publication of positive data related to its proprietary gene expression test,...

Sono-Tek Announces Fiscal Second Quarter and First Half 2025 Earnings Conference Call

Sono-Tek Announces Fiscal Second Quarter and First Half 2025 Earnings Conference Call

Oct 8, 2024

Conference Call on Tuesday, October 15, 2024 at 10:00 am ET MILTON, NY, October 8, 2024 – PRISM MediaWire - Sono-Tek Corporation (NASDAQ: SOTK), the leading developer and manufacturer of ultrasonic coating systems, today announced that the Company will hold a conference call to discuss its fiscal second quarter and first half 2025 financial results, ended August 31, 2024, on Tuesday, October 15, 2024 at 10:00 am ET. The second quarter and first half FY 2025 financial results press release will...

SKYX Provides Corporate Update, including Significant Insider Buying

SKYX Secures $11 Million Strategic Investment at $2.00 Per Share, Preferred Stock Convertible, Led by Global Marriott Hotel-Chain Developer, Lance Shaner, Owner of over 60 Hotels, Primarily Marriotts

Oct 7, 2024

Management Emphasizes That It Has Sufficient Cash to Achieve Its Goals Including Recently Announced Collaborations and Being Cash Flow Positive During 2025 The $11 Million Investment includes Leading Builders and Hotel Developers MIAMI, October 07, 2024 - PRISM MediaWire - SKYX Platforms Corp. (NASDAQ: SKYX) (d/b/a SKYX Technologies) (the "Company" or "SKYX"), a highly disruptive smart platform technology company with more than 97 issued and pending patents globally and over 60 lighting and...

AmpliTech Group Announces Receipt of Notice of Allowance for Patents in 5G and Cryogenic Technology For Quantum Computing Applications

AmpliTech Group Announces Receipt of Notice of Allowance for Patents in 5G and Cryogenic Technology For Quantum Computing Applications

Oct 7, 2024

Hauppauge, NY, October 7, 2024 – PRISM MediaWire - AmpliTech Group, Inc. (Nasdaq: AMPG, AMPGW), a designer, developer, and manufacturer of state-of-the-art signal processing components for satellite, Public and Private 5G, and other communications networks, including the design of complete 5G/6G systems and a global distributor of packages and lids for integrated circuits assembly, today is pleased to announce that the United States Patent and Trademark Office (USPTO) has issued a Notice of...

Entrevista exclusiva com Newton Santana, Presidente e Diretor da BEVAP Bioenergia, em antecipação ao Biocombustíveis Brasil 2024

Oct 5, 2024

London, October 5, 2024 - PRISM MediaWire - Temos o prazer de compartilhar uma entrevista exclusiva com Newton Santana, Presidente e Diretor da BEVAP Bioenergia, em antecipação ao Biocombustíveis Brasil 2024 que acontecerá nos dias 27 e 28 de novembro em São Paulo. Newton Santana, Presidente e Diretor da BEVAP Bioenergia Nesta conversa perspicaz, Newton revela as estratégias de ponta da BEVAP para manter a liderança em inovação e sustentabilidade, ao mesmo tempo que oferece uma perspectiva...

Exclusive interview with Newton Santana, President and Director of BEVAP Bioenergy, ahead of Biofuels Brazil 2024

Oct 5, 2024

London, October 5, 2024 - PRISM MediaWire - We are pleased to share an exclusive interview with Newton Santana, President and Director of BEVAP Bioenergy, ahead of Biofuels Brazil 2024, which will take place on November 27-28 in São Paulo. Newton Santana, President and Director of BEVAP Bioenergy In this insightful conversation, Newton reveals BEVAP's cutting-edge strategies to maintain leadership in innovation and sustainability while offering a glimpse into the future of the biofuels...

Entrevista exclusiva con Newton Santana, Presidente y Director de BEVAP Bioenergía, en anticipación a Biocombustibles Brasil 2024

Oct 5, 2024

Londres, October 5, 2024 - PRISM MediaWire - Nos complace compartir una entrevista exclusiva con Newton Santana, Presidente y Director de BEVAP Bioenergía, en anticipación a Biocombustibles Brasil 2024, que se llevará a cabo los días 27 y 28 de noviembre en São Paulo. Newton Santana, Presidente y Director de BEVAP Bioenergía En esta conversación perspicaz, Newton revela las estrategias de vanguardia de BEVAP para mantener el liderazgo en innovación y sostenibilidad, al mismo tiempo que ofrece...

Press Releases Highlights – September 30 – October 4, 2024

Press Releases Highlights – September 30 – October 4, 2024

Oct 4, 2024

Press Releases Highlights – September 30 – October 4, 2024 - provided by PRISM MediaWire

Oncocyte Signs Leading Transplant Centers in US and Germany

Oncocyte Signs Leading Transplant Centers in US and Germany

Oct 2, 2024

GraftAssure™ research assay adopted by two research hospitals that are top-five-in-country by organ transplant volume Company clears first stage gate in clinical product development process and has submitted a Q-Sub to the FDA IRVINE, Calif., Oct. 02, 2024 - PRISM MediaWire - Oncocyte Corporation (Nasdaq: OCX) (“Oncocyte” or the “Company”), a diagnostics technology company, today announced that its new customers include two leading transplant university hospitals in the U.S. and Germany. Both...

Oncocyte Signs Leading Transplant Centers in US and Germany

Oncocyte Corporation Announces $10.2 Million Private Placement of Securities Priced At-The-Market Under Nasdaq Rules

Oct 2, 2024

Company Obtains Participation from New and Existing Investors, Including Strategic Partner Bio-Rad Laboratories IRVINE, Calif., Oct. 02, 2024 - Oncocyte Corporation (Nasdaq: OCX) (“Oncocyte” or the “Company”), a diagnostics technology company, today announced that it has entered into a securities purchase agreement (the “Purchase Agreement”) with new and existing investors, including Bio-Rad Laboratories, Inc., one of the Company’s strategic partners. The gross proceeds to the Company from the...

Neon Bloom To Partner With Elevated International For 3rd Party Business Development

Neon Bloom To Partner With Elevated International For 3rd Party Business Development

Oct 2, 2024

NEWPORT BEACH, CA, October 2, 2024 - PRISM MediaWire - Neon Bloom, Inc. (OTC PINK: NBCO)announced today that it has finalized a business relationship with Elevated International, a US entity specializing in 3rd party business development. Elevated International specializes in connecting individuals and businesses with transactional and software solutions in the e-Commerce, Enterprise, and Retail environments. This relationship with Elevated International is expected to result in...

BioStem Technologies Initiates BR-AC-DFU-101 Clinical Trial to Study BioREtain® in Diabetic Foot Ulcers

BioStem Technologies Initiates BR-AC-DFU-101 Clinical Trial to Study BioREtain® in Diabetic Foot Ulcers

Oct 2, 2024

Strategic head-to-head study of BR-AC vs. standard of care aims to demonstrate healing superiority potential to support increased payor coverage and market growth The study will be conducted in 60 patients at 10 sites across the U.S. and the first patients have begun treatment POMPANO BEACH, Florida, October 2, 2024 - BioStem Technologies, Inc. (OTC: BSEM), a leading MedTech company focused on the development, manufacture, and commercialization of placental-derived biologics for advanced wound...

SPZI: JP3E announces First Shipment of Chicken Paws to China

SPZI: JP3E announces First Shipment of Chicken Paws to China

Oct 1, 2024

NEW YORK, Oct 1, 2024 - PRISM MediaWire - JP 3E Holdings, Inc. (OTC: SPZI), through its wholly owned subsidiary, JP Energy Global, PTE, LTD, is excited to announce the evolution in its February 2024 commodity contract for Grade A Chicken Paws (https://finance.yahoo.com/news/spzi-jp-energy-global-sets-175300176.html). The first shipment has been loaded and departed in September 2024, for Grade A Chicken Paws to China.The chicken paws are sourced from Brazil, South America, in what marks the...

BIEI: Premier Graphene’s Mexico Affiliate and Business Partner, HGI Industrial Technologies, Executes Joint Venture with Santa Rosa Green Seeds to Advance Industrial Hemp Initiatives in Mexico

BIEI: Premier Graphene’s Mexico Affiliate and Business Partner, HGI Industrial Technologies, Executes Joint Venture with Santa Rosa Green Seeds to Advance Industrial Hemp Initiatives in Mexico

Oct 1, 2024

Premier Fortifies its Pathway to Full-Scale, High-Quality Graphene Production, with the Most Critical Raw Material/Component – High-Quality Hemp, at Low Cost EL CENTRO, Calif., October 1, 2024 - PRISM MediaWire - Premier Graphene Inc. (OTC: BIEI), announced today that HGI Industrial Technologies, Premier Graphene’s Mexico affiliate and business partner, unveiled a joint venture with Santa Rosa Green Seeds. As one of only two companies to receive this coveted hemp license from the Mexican...

Halberd & Athena GTX Report Initial Success of WatchDawg® PTSD Treatment Pilot Study

Halberd & Athena GTX Report Initial Success of WatchDawg® PTSD Treatment Pilot Study

Oct 1, 2024

Ten Military Veteran Volunteers Participated in the Pilot Study Enabled by Athena GTX Health Monitoring System Jackson Center, PA, October 1, 2024 – PRISM MediaWire - Halberd Corporation (OTC PINK: HALB) released the results of the recently completed WatchDawg® Pilot Study. Ten (10) military veterans participated in the study where they received pharmaceuticals (LDX) and nutraceuticals, along with 24/7 access to mental health therapies provided by Yogani/Exalted Warrior Foundation....

The Awareness Group (TAG) Launches TAG Capital to Drive Renewable Energy Financing

The Awareness Group (TAG) Launches TAG Capital to Drive Renewable Energy Financing

Oct 1, 2024

Will Provide Fund Management Services for TAG’s Innovative PPAs and Service and Monetize TAG Loan Portfolios and Investment Tax Credits Scottsdale, AZ, October 1, 2024 - PRISM MediaWire -The Awareness Group (OTC: FHLD) (“TAG”), a rising leader in the alternative energy industry, is excited to announce the launch of TAG Capital—a dynamic new division under TAG Financial, aiming to disrupt the future of renewable energy project financing. TAG Capital will act as the financial backbone of the...

AmpliTech Group Announces Receipt of Notice of Allowance for Patents in 5G and Cryogenic Technology For Quantum Computing Applications

AmpliTech Group Received Nasdaq Notification of Non-Compliance with Listing Rules 5550(a)(2)

Sep 30, 2024

Company Expects To Regain Compliance Within Specified Period HAUPPAUGE, N.Y., Sept. 30, 2024 - PRISM MediaWire - AmpliTech Group, Inc. (Nasdaq: AMPG, AMPGW) (the “Company”), a designer, developer, and manufacturer of state-of-the-art signal processing components for satellite, Public and Private 5G, and other communications networks, including the design of complete 5G/6G systems and a global distributor of packages and lids for integrated circuits assembly, received a notice (the “Notice”)...

SPZI: JP3E announces First Shipment of Chicken Paws to China

SPZI: JP 3E Completes Second Aluminum Shipment with Bloxcross Trade Finance Platform, 1500 MT Shipped to Date

Sep 30, 2024

NEW YORK, Sept. 30, 2024 – PRISM MediaWire - JP 3E Holdings, Inc. (OTC: SPZI), formerly Spooz, Inc., has achieved another major milestone by completing its second shipment of Aluminum Ingot (A7) through its innovative Trade Finance platform in collaboration with Bloxcross. This latest shipment of 1,000 metric tons (MT) follows an initial shipment of 500MT, bringing the total shipped to date to 1,500MT. As global demand for aluminum continues to soar JP 3E is well positioned to capitalize on...

SS Innovations Welcomes Mr. Tim Adams, Leader in the Health Care Industry, to Board

SS Innovations Welcomes Mr. Tim Adams, Leader in the Health Care Industry, to Board

Sep 30, 2024

Tim Adams to serve as Independent Board Director FORT LAUDERDALE, FL, September 30, 2024 - PRISM MediaWire - SS Innovations International, Inc. (the “Company” or “SS Innovations”) (OTC: SSII), a developer of innovative surgical robotic technologies dedicated to making world-class robotic surgery affordable and accessible to a global population, is pleased to announce the addition of Mr. Tim Adams to its Board of Directors, where he will serve as an Independent Director. Mr. Adams is a...

BioStem Technologies Initiates BR-AC-DFU-101 Clinical Trial to Study BioREtain® in Diabetic Foot Ulcers

BioStem Technologies, Inc. Files Form 10 with the Securities and Exchange Commission and Submits Nasdaq Application for Uplisting

Sep 30, 2024

Nasdaq listing aims to increase market visibility and global liquidity opportunities as BioStem advances its commercial and clinical initiatives amid record revenue growth Pompano Beach, FL, September 30, 2024 - PRISM MediaWire - BioStem Technologies, Inc. (OTC: BSEM) (“BioStem” or the “Company”), a leading MedTech company focused on the development, manufacture and commercialization of placental-derived biologics, announces the filing of a Form 10 registration statement (the “Registration...

Dr. Robert Langer, Co-Founder of Moderna, Joins Scientific Advisory Board of Klotho Neurosciences, Inc. (KLTO)

Dr. Robert Langer, Co-Founder of Moderna, Joins Scientific Advisory Board of Klotho Neurosciences, Inc. (KLTO)

Sep 30, 2024

Renowned Biotech Leader to Contribute Expertise in Neuroscience and Therapeutics Development New York, NY, September 30, 2024 - PRISM MediaWire - Klotho Neurosciences, Inc. (NASDAQ: KLTO), a cutting-edge biotechnology company focused on developing innovative therapies for neurodegenerative diseases and promoting healthy longevity, is proud to announce that Dr. Robert Langer, co-founder of Moderna, has joined its Scientific Advisory Board. In addition to lending his world-class scientific...

Globe Small Cap Research Releases Company Report: SMC’s ChainTrade Platform Poised to Revolutionize Capital Markets’ Data Intelligence

Globe Small Cap Research Releases Company Report: SMC’s ChainTrade Platform Poised to Revolutionize Capital Markets’ Data Intelligence

Sep 27, 2024

BOCA RATON, FL, September 27, 2024 - PRISM MediaWire - SMC Entertainment, Inc. ("SMC" or the "Company") (OTC: SMCE), an incubator company focused on acquisition and support of commercialized services and technology (Fintech) companies, announced today that Globe Small Cap Research, released their corporate report on SMC to coincide with the Company’s ChainTrade Platform going live. ChainTrade deploys an array of vertically focused AI Applications specifically designed for the Capital Markets....

DRYWORLD Teams Up with Spartan Race to Revolutionize Performance Apparel in Adventure Racing

DRYWORLD Teams Up with Spartan Race to Revolutionize Performance Apparel in Adventure Racing

Sep 26, 2024

Cutting-Edge Gear to Empower Athletes in the Ultimate Endurance Challenge Strategic Alliance Unites Innovation and Performance for Unprecedented Racing Success Santa Barbara, September 26, 2024 - PRISM MediaWire - DRYWORLD Brands Inc. (OTC: IBGR), a leading performance athletic brand, is excited to announce a ground-breaking partnership with Spartan Race, the global leader in extreme participation sports. The strategic alliance sees DRYWORLD become the exclusive and official compression...

The Awareness Group (TAG) Launches TAG Capital to Drive Renewable Energy Financing

The Awareness Group (TAG) Launches Game-Changing TAG Financial Services (TFS)

Sep 26, 2024

Strategic Acquisition of Southwest Financial Services Creates a Dynamic New Fintech Subsidiary for Project Financing and Lending Solutions TFS to Revolutionize Financing Options for TAG GRID Members, Expanding Opportunities in the Renewable Energy Sector Scottsdale, AZ, September 26, 2024 – PRISM MediaWire - The Awareness Group (OTC: FHLD) (“TAG”), an emerging leader in the alternative energy sector, today introduced TAG Financial Services (TFS), a groundbreaking division of TAG Financial set...

LuxUrban Hotels Inc. Reports Second Quarter 2024 Financial Results

LuxUrban Hotels Inc. Reports Second Quarter 2024 Financial Results

Sep 25, 2024

Miami, Florida, September 25, 2024 – PRISM MediaWire - LuxUrban Hotels Inc. (Nasdaq: LUXH), a hospitality company that leases entire hotels on a long-term basis, manages these hotels, and rents out rooms to guests in the properties it leases, today announced its financial results for the second quarter ended June 30, 2024 (“Q2 2024”). The Company has also submitted its quarterly report on Form 10-Q to the U.S. Securities and Exchange Commission. Q2 2024 Financial Overview: Net Rental Revenue:...

PRISM MarketView Features Q&A with Dr. Michael Chancellor: Lipella Pharmaceuticals Advances Innovative Treatments for Hemorrhagic Cystitis During Urology Awareness Month

PRISM MarketView Features Q&A with Dr. Michael Chancellor: Lipella Pharmaceuticals Advances Innovative Treatments for Hemorrhagic Cystitis During Urology Awareness Month

Sep 25, 2024

NEW YORK, September 25, 2024 - PRISM MediaWire - PRISM MarketView presents an exclusive Q&A with Dr. Michael Chancellor, Co-founder and Chief Medical Officer of Lipella Pharmaceuticals, Inc. (Nasdaq: LIPO). In this interview, Dr. Chancellor provides insights into the company's latest advancements in urological treatments, particularly in recognition of Urology Awareness Month, and discusses the significant progress made in the development of therapies for hemorrhagic cystitis (HC)....

LuxUrban Hotels to Host Webcast to Review the Financial Results for the Second Quarter of 2024

LuxUrban Hotels to Host Webcast to Review the Financial Results for the Second Quarter of 2024

Sep 25, 2024

Conference Call and Webcast to be held on September 25, 2024 at 5:00 PM ET MIAMI, Florida, September 25, 2024 - PRISM MediaWire - LuxUrban Hotels Inc. (“LuxUrban” or the “Company”) (Nasdaq: LUXH), which secures long-term operating rights for entire hotels through Master Lease Agreements (MLA) under which it manages the hotel and rents out, on a short-term basis, rooms to business and vacation travelers, will host a webcast to review the results of the 2nd quarter of 2024 on...

BIEI: Premier Graphene’s Mexico Affiliate and Business Partner, HGI Industrial Technologies, Executes Joint Venture with Santa Rosa Green Seeds to Advance Industrial Hemp Initiatives in Mexico

Premier Graphene Receives Confirmatory Concrete and Mortar Test Results from Global Leader in Sustainable Construction

Sep 25, 2024

Global Leader Nears Final Testing Phase Which Could Lead to Long-Term Supply Agreements El Centro, CA, September 25, 2024 - PRISM MediaWire - Premier Graphene Inc. (OTC: BIEI) President Pedro Mendez recently held a Zoom meeting with the research and development team from one of the world’s largest construction materials companies (the “Company”) on Tuesday, September 24, 2024. During the meeting, the global leader in sustainable construction independently validated data originally reported by...

Lipella Pharmaceuticals Reports Encouraging Early Tolerability Results in Phase 2a Trial of LP-310 for Oral Lichen Planus

Lipella Pharmaceuticals Reports Encouraging Early Tolerability Results in Phase 2a Trial of LP-310 for Oral Lichen Planus

Sep 24, 2024

PITTSBURGH, Sept. 24, 2024 – PRISM MediaWire - Lipella Pharmaceuticals Inc. (Nasdaq: LIPO) (“Lipella” or the “Company”), a clinical-stage biotechnology company focused on addressing serious diseases with significant unmet needs, today announced an update on its ongoing multi-center Phase 2a clinical trial evaluating LP-310 for the treatment of Oral Lichen Planus (OLP). The Company reported that three participants have completed the four-week treatment with LP-310, an oral rinse, with...